English (United States)
This Vaccine Toolkit provides the latest evidence-based information about vaccines approved for use to prevent COVID-19 infections. View vaccine drug monograph information as well as patient education resources. This page will continue to be updated as additional vaccines receive approval and new information becomes available.
CDC and FDA Suspend Johnson & Johnson Vaccine Administration Pending Safety Review
CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine. In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia).
Join John McConnell, Editor-in-Chief of The Lancet Infectious Diseases, and Ylann Schemm, Director of the Elsevier Foundation and Corporate Responsibility at Elsevier in an engaging discussion about how COVID-19 vaccines work and their safety and efficacy in preventing infection. John will share insights into the public's most frequently asked questions. Join us for an invaluable opportunity to secure answers to your own pressing questions.
COVID-19 (coronavirus disease 2019) is a respiratory tract infection with a newly recognized coronavirus, SARS-CoV-2, thought to have originated as a zoonotic virus that has mutated or otherwise adapted in ways that allow human pathogenicity
User acknowledges that these COVID-19-related materials are provided for use at no charge as part of Elsevier’s efforts to support healthcare providers and patients. They information contained within the website is intended as a supplement to, and not a substitute for, the knowledge, expertise, skill and judgment of healthcare professionals involved in patient care. The content within this page may not be re-used, modified or re-distributed without prior written permission.
Cookies are used by this site. To decline or learn more, visit our cookies page.